Bayer is boosting its precision oncology efforts with a molecular database from health tech firm ConcertAI.  | Bayer is ...

ConcertAI has announced an agreement that will allow Bayer to utilise its Translational360 and AI software-as-a-service (SaaS ...

The firms will explore molecular mechanisms and patient responses in cancer to inform development of new therapies.

The expansion strengthens Bayer’s ability to deliver health-focused products more efficiently across North America.